Capita plc
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS IN ACCORDANCE WITH DTR 3.1.4R AND DTR
3.1.2R
On 27 February 2014 Gillian Sheldon, Senior Independent Director of Capita plc
(the `Company'), purchased 1,000 Ordinary shares of 2 1/15p each in the Company
at a price of £11.59 per share. The transaction took place in London, United
Kingdom.
On 28 February 2014, the following transaction took place in relation to
Ordinary shares of 2 1/15p each in the Company in respect of the following
Directors of the Company:
Andy Parker, Gordon Hurst, Maggi Bell, Vic Gysin and Dawn Marriott-Sims
Grant of Options - Deferred Annual Bonus Plan ("DABP")
The Directors referred to above were awarded nil cost matching share awards
under the DABP, as follows:
Andy Parker: 56,130 Ordinary Shares
Gordon Hurst: 50,086 Ordinary Shares
Maggi Bell: 41,450 Ordinary Shares
Vic Gysin: 67,356 Ordinary Shares
Dawn Marriott-Sims: 17,270 Ordinary Shares
The above transaction took place in London, United Kingdom.
Contact: Francesca Todd, Deputy Group Company Secretary, 020 7202 0641
Date of Notification: 28 February 2014
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.